l 158809 has been researched along with Hyperplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barber, L; Dalen, H; Davies, MG; Fulton, GJ; Hagen, PO; Svendsen, E | 1 |
| Asada, K; Jin, D; Kondo, K; Matsuyama, N; Miyazaki, M; Nishimoto, M; Sasaki, S; Sawada, Y; Takai, S; Yuda, A | 1 |
2 other study(ies) available for l 158809 and Hyperplasia
| Article | Year |
|---|---|
Characterisation of angiotensin II receptor mediated responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Endothelium, Vascular; Graft Occlusion, Vascular; Hyperplasia; Imidazoles; Jugular Veins; Microscopy, Electron, Scanning; Muscle Contraction; Muscle, Smooth, Vascular; Rabbits; Receptors, Angiotensin; Tetrazoles; Tunica Intima | 1996 |
Angiotensin II receptor antagonist, L-158,809, prevents intimal hyperplasia in dog grafted veins.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Dogs; Hyperplasia; Imidazoles; In Vitro Techniques; Placebos; Receptors, Angiotensin; Tetrazoles; Tunica Intima; Veins | 2000 |